Work

Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies

Year: 2022

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2022.2068001

Authors: Ola Landgren, Dickran Kazandjian, Murielle Roussel, Jagoda Jasielec, Dominik Dytfeld, Aparna Anderson, Tara A. Kervin, Karim Iskander, Ian McFadden, Andrzej J. Jakubowiak

Institutions: University of Miami Health System, Sylvester Comprehensive Cancer Center, National Institutes of Health, National Cancer Institute, Institut universitaire du cancer de Toulouse Oncopole, University of Chicago, Poznan University of Medical Sciences, Statistics Collaborative, Amgen (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W4280514659

FWCI: 0.364

Cites: 29

Cited by: 5

Related to: 10